| 1 |
Takeuchi T, Flannery AH, Liu LJ, et al. Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions [J]. Crit Care, 2025, 29(1): 128.
|
| 2 |
Liu A, Tan B, Yang P, et al. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential [J]. Front Immunol, 2024, 15: 1487576.
|
| 3 |
Yang Y, Deng X, Li W, et al. Targeting the epigenetic regulation of ferroptosis: a potential therapeutic approach for sepsis-associated acute kidney injury [J]. Clin Epigenetics, 2025, 17(1): 57.
|
| 4 |
Li D, Chan HY, Yu ASL, et al. Clustering analysis of multi-site electronic health records reveals distinct subphenotypes in stage-1 acute kidney injury [J]. Commun Med (Lond), 2025, 5(1): 274.
|
| 5 |
Oh W, Takkavatakarn K, Al-Taie Z, et al. Personalized fluid management in patients with sepsis and acute kidney injury: a casual machine learning approach [J]. Crit Care Explor, 2025, 7(12): e1354.
|
| 6 |
Qi J, Wu W, Wang J, et al. Selection of timing of continuous renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomized controlled trials [J]. PLoS One, 2025, 20(3): e320351.
|
| 7 |
Xu X, Zeng T, Chen S, et al. Acute kidney injury: pathogenesis and therapeutic interventions [J]. Mol Biomed, 2025, 6(1): 61.
|
| 8 |
Veltkamp DMJ, Porras CP, Gant CM, et al. Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis [J]. Nephrol Dial Transplant, 2025, 40(11): 2143-2158.
|
| 9 |
Ren L, Cui H, Wang Y, et al. The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects [J]. Biomed Pharmacother, 2023, 161: 114465.
|
| 10 |
Wang T, Huang Y, Zhang X, et al. Advances in metabolic reprogramming of renal tubular epithelial cells in sepsis-associated acute kidney injury [J]. Front Physiol, 2024, 15: 1329644.
|
| 11 |
Gao Z, Chen X. Fatty acid β-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities [J]. Front Pharmacol, 2022, 13: 805281.
|
| 12 |
Huang J, Meng P, Liang Y, et al. Tubular CD44 plays a key role in aggravating AKI through NF-κB p65-mediated mitochondrial dysfunction [J]. Cell Death Dis, 2025, 16(1): 119.
|
| 13 |
Xu S, Jia P, Fang Y, et al. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation [J]. Kidney Int, 2022, 101(5): 987-1002.
|
| 14 |
Zeng S, Wang J, Guan C, et al. Fenofibrate alleviates sepsis-associated acute kidney injury by enhancing renal fatty acid oxidation [J]. BMC Pharmacol Toxicol, 2025, 26(1): 160.
|
| 15 |
Li J, Liu Y, Bai J, et al. Dexmedetomidine alleviates renal tubular ferroptosis in sepsis-associated AKI by KEAP1 regulating the degradation of GPX4 [J]. Eur J Pharmacol, 2023, 961: 176194.
|
| 16 |
Fu Y, Wang W, Gong N, et al. Neutrophil and neutrophil extracellular traps in acute kidney injury: from mechanisms to treatments [J]. Front Immunol, 2025, 16: 1688207.
|
| 17 |
Sanghavi SF. Corticosteroids-a not-so-novel treatment for sepsis-associated AKI [J]. JAMA Netw Open, 2025, 8(5): e2512286.
|
| 18 |
Wang Y, Wang N, Qu L, et al. Nanomedicine for acute kidney injury: precision delivery strategies, therapeutic breakthroughs, challenges, and future perspectives [J]. Int J Nanomedicine, 2025, 20: 14015-14031.
|
| 19 |
Wu W, Lan W, Jiao X, et al. Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives [J]. Crit Care, 2025, 29(1): 168.
|
| 20 |
Wan D, Luo X, He M, et al. Exploring trajectories of acute kidney injury in the intensive care unit: a population-based cohort study [J]. Sci Rep, 2025, 15(1): 33056.
|
| 21 |
Zarbock A, Nadim MK, Pickkers P, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup [J]. Nat Rev Nephrol, 2023, 19(6): 401-417.
|
| 22 |
Chiang H, Liang C, Hsiao Y, et al. Sepsis-associated acute kidney disease incidence, trajectory, and outcomes [J]. Kidney Med, 2025, 7(3): 100959.
|
| 23 |
Goeddel LA, Hernandez M, Koffman L, et al. Fine-mapping the association of acute kidney injury with mean arterial and central venous pressures during coronary artery bypass surgery [J]. Anesth Analg, 2025, 140(6): 1439-1449.
|
| 24 |
Cieza Terrones M, Rodríguez Tudero C, Nanwani AC, et al. Extreme fluid accumulation syndrome or compartmental balance disorder? A sepsis-associated acute kidney injury case report and literature review [J]. J Clin Med, 2025, 14(23): 8310.
|
| 25 |
Nordin NZ, Akhtar W, Ostermann M. Fluid management in sepsis associated acute kidney injury [J]. J Crit Care, 2025, 90: 155188.
|
| 26 |
Aletras G, Bachlitzanaki M, Stratinaki M, et al. Unraveling acute cardiorenal syndrome: predictors and consequences in acute heart failure [J]. J Clin Med, 2025, 14(7): 2270.
|
| 27 |
Banerjee D, Ali MA, Wang AY, et al. Acute kidney injury in acute heart failure-when to worry and when not to worry? [J]. Nephrol Dial Transplant, 2024, 40(1): 10-18.
|
| 28 |
Vasquez F, Tiscornia C, Lorca-Ponce E, et al. Cardiorenal syndrome: molecular pathways linking cardiovascular dysfunction and chronic kidney disease progression [J]. Int J Mol Sci, 2025, 26(15): 7740.
|
| 29 |
Bianco M, Di Nora C, De Maria R, et al. SGLT2-is in acute heart failure [J]. J Clin Med, 2025, 14(21): 7799.
|
| 30 |
Hou J, Lin Z, Li J, et al. Integration of continuous renal replacement therapy in patients on extracorporeal life support: timing, modality, and future directions [J]. Ren Fail, 2025, 47(1): 2604452.
|
| 31 |
Paragliola V, Gamardella M, Franchin L, et al. Percutaneous mechanical circulatory support devices in cardiogenic shock: a narrative review in light of recent evidence [J]. J Clin Med, 2025, 14(21): 7731.
|
| 32 |
Schaub JA, Alaba M, Kretzler M. A holistic approach to AKI: integrating clinical and molecular data in the human kidney [J]. Semin Nephrol, 2025, 45(6): 151663.
|
| 33 |
Zeng F, Yang Z, Wang Z. Integrated transcriptomic and single-cell RNA-seq analysis identifies CLCNKB, KLK1 and PLEKHA4 as key gene of AKI-to-CKD progression [J]. Front Immunol, 2025, 16: 1628962.
|
| 34 |
Chen J, Xu X, Cai Y, et al. Acute kidney injury over the past decade: from definition evolution to pathogenesis insights and innovative therapeutic strategies [J]. Cell Mol Life Sci, 2026, 83(1): 156.
|
| 35 |
Epler K, Fuhrman DY, Hebbar S, et al. Bench to bedside: translating discoveries to clinical care in kidney disease [J]. Nephron, 2025, 17: 1-8.
|
| 36 |
Matarneh A, Akkari A, Sardar S, et al. Beyond creatinine: diagnostic accuracy of emerging biomarkers for AKI in the ICU – a systematic review [J]. Ren Fail, 2025, 47(1): 2556295.
|
| 37 |
Zhu Y, Lv C, Qiao Y, et al. Transformation of acute kidney injury to chronic kidney disease: the interaction between mitophagy and NLRP3 inflammasome [J]. Front Mol Biosci, 2025, 12: 1643829.
|
| 38 |
Regenburgh De La Motte L, Bassani B, Trepiccione F, et al. Preclinical models of cardio-renal syndrome: a systematic review [J]. Am J Physiol Cell Physiol, 2025, 329(6): C1857-C1872.
|
| 39 |
Welzel C, Ertaylan G, Babina IS, et al. Regulating complexity in AI-enabled omics and multi-omics technologies for precision medicine [J]. NPJ Digit Med, 2026, 9(1): 247.
|